Ambu and Medical Advisory Fuel Medical Group Announce Partnership

June 30, 2020

Ambu Inc., a rapidly growing pioneer of sterile, single-use medical devices, and Fuel Medical Group, the leading business advisory resource for ENTs, audiologists, otologists, and universities, have entered into a partnership the companies announced today.

Under the agreement, Ambu will offer Fuel Medical entrée to a broad hospital market for services, including marketing, finance, digital strategies, professional development, and recruiting as well as advising practices on maximizing revenue and streamlining administrative operations.

In turn, Fuel Medical, which is based in Camas, Washington, will broaden Ambu’s reach into medical practices by offering an array of state-of-the-art, single-use endoscopes that include rhinolaryngoscopes, bronchoscopes, duodenoscopes, and advanced monitors that increase safety and efficiency.

“This is a perfect match that will enable both companies to expand their reach into new and growing markets,” said Juan Jose Gonzalez, CEO of Ambu A/S. “Fuel Medical has such a strong reputation as a leader in a business advisory that it was difficult to overlook their success. We are thrilled with the partnership and see an incredibly productive future.”

“We couldn’t be more excited about this partnership as we both believe in each other’s missions,” added Brendan Ford, Fuel Medical Group’s Co-Founder. “We have a lot of overlap in our goals, specifically when it comes to innovative ideas and building lasting relationships with our customers.”

Shawn Parker, Fuel Medical Group’s Co-Founder, said “Single-use scopes are ideal for ENT practices as they provide tremendous value due to their sanitary nature. If we can offer safer products to our members, we can help them provide exceptional care to their patients.”

Specifics about the deal were not disclosed.

SourceAmbu
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version